News Industry News CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction May 29, 2024
News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019
News Industry News TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI February 17, 2016
News Industry News TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI November 04, 2015
News Industry News FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa October 20, 2015
News Industry News Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM July 27, 2015
News Industry News OrbusNeich Announces Enrollment of First Patient in China Recovery Study July 20, 2015